Cite
HARVARD Citation
Mattila, J. et al. (2019). Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17. Journal of biomedical materials research. 107 (1), pp. 29-36. [Online].